Literature DB >> 6215197

Human dendritic cells: major stimulators of the autologous and allogeneic mixed leucocyte reactions.

M K Crow, H G Kunkel.   

Abstract

Highly purified preparations of dendritic cells were obtained from human peripheral blood. Loosely adherent cells were selected and subsequently depleted of phagocytic cells and Fc receptor positive cells to yield the dendritic cell fraction. These isolates contained greater than 90% Ia positive cells, with many of the cells showing the morphological characteristics of the murine dendritic cell. These preparations were compared to other mononuclear cell fractions as stimulating cells in autologous and allogeneic mixed leucocyte reactions. The dendritic cell preparations provided the most potent stimulus for autologous T cell proliferation, with 10 x more 3H-thymidine incorporated by T lymphocytes incubated with autologous dendritic cells than with any other non-T cell preparation. Dendritic cells were also the most stimulatory cell in the allogeneic mixed leucocyte reaction, although the non-adherent subpopulation produced some stimulation of allogeneic T cells. In separate experiments, it was determined that B cells could be activated by pokeweed mitogen to vigorously stimulate autologous T cells. Visual observation of cluster formation in cultures containing dendritic cells and autologous T cells suggests that the capacity for intimate cell contact may be an important property of the dendritic cell in vivo.

Entities:  

Mesh:

Year:  1982        PMID: 6215197      PMCID: PMC1536501     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

2.  Lymphocyte transformation induced by autologous cells: stimulation by cultured lymphoblast lines.

Authors:  M E Weksler; G Birnbasum
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

3.  The human autologous mixed lymphocyte reaction. I. Suppression by macrophages and T cells.

Authors:  J S Smolen; S O Sharrow; J P Reeves; W A Boegel; A D Steinberg
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

4.  Activation of suppressor T cells in human autologous mixed lymphocyte culture.

Authors:  J B Smith; R P Knowlton
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

5.  Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice.

Authors:  R M Steinman; M D Witmer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus.

Authors:  T Sakane; A D Steinberg; I Green
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

7.  Autologous stimulation of human lymphocyte subpopulation.

Authors:  G Opelz; M Kiuchi; M Takasugi; P I Terasaki
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

8.  Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells.

Authors:  R A Vande Stouwe; H G Kunkel; J P Halper; M E Weksler
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

9.  Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes.

Authors:  M M Kuntz; J B Innes; M E Weksler
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution.

Authors:  R M Steinman; Z A Cohn
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

View more
  45 in total

1.  Human rheumatoid synovial and normal blood dendritic cells as antigen presenting cell--comparison with autologous monocytes.

Authors:  K Waalen; O Førre; J Teigland; J B Natvig
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

Review 2.  Modification of accessory molecule signaling.

Authors:  Mary K Crow
Journal:  Springer Semin Immunopathol       Date:  2006-05-16

3.  Nodular alteration of the paracortical area. An in situ immunohistochemical analysis of primary, secondary, and tertiary T-nodules.

Authors:  J J van den Oord; C De Wolf-Peeters; V J Desmet; K Takahashi; Y Ohtsuki; T Akagi
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

4.  CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells.

Authors:  L J Zhou; T F Tedder
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

5.  The distinct surface of human blood dendritic cells, as observed after an improved isolation method.

Authors:  P S Freudenthal; R M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

6.  Impairment of autologous mixed lymphocyte reaction in the spleen and peripheral blood lymphocytes of patients with idiopathic portal hypertension.

Authors:  H Yamaue; H Tanimura; M Iwahashi; T Tsunoda; M Tani; M Tamai; M Inoue
Journal:  Gastroenterol Jpn       Date:  1990-04

Review 7.  Dendritic cells in rheumatoid inflammation.

Authors:  K Waalen; O Førre; J B Natvig
Journal:  Springer Semin Immunopathol       Date:  1988

8.  Some properties of dendritic macrophages from peripheral lymph.

Authors:  R Barfoot; S Denham; L A Gyure; J G Hall; S M Hobbs; L E Jackson; D Robertson
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

9.  Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells.

Authors:  B D Hock; G C Starling; P B Daniel; D N Hart
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

Review 10.  Molecular Cross-Talk at the Feto-Maternal Interface.

Authors:  Gendie E Lash
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-18       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.